NBY
Novabay Pharmaceuticals
Description:
NovaBay Pharmaceuticals Inc. (NBY) is a California-based innovator in the field of ocular health, dedicated to developing advanced medical devices and therapeutics aimed at treating eye infections and inflammation. Utilizing its proprietary technologies, the company addresses critical unmet clinical needs within the expanding eye care market. NovaBay is strategically positioned to enhance patient outcomes while offering a compelling investment opportunity for institutional investors looking to capitalize on advancements in healthcare and medical devices.
Address:
2000 POWELL STREET, EMERYVILLE, CA, UNITED STATES, 94608
Fiscal year end:
December
Market capitalization:
$136 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-100%
How much will you get:
$0
Prices dates:
30-10-2015: $3,373.46 and 31-10-2025: $1.15